USP 797 went through its final revision approval in December. The new standard becomes official June 1. What is it, who will it affect, and where will it be implemented? The United States Pharmacopeia ...
You are invited to participate in a national survey regarding awareness of United States Pharmacopeia (USP) 797 and its practical effects on ASCs. USP 797 is the regulation that deals with sterile ...
While many health systems have taken steps to address these new standards, developing a proactive strategy can be challenging. Leveraging IV compounding automation to streamline cleanroom processes ...
MINNEAPOLIS--(BUSINESS WIRE)-- DaVita Clinical Research ® (DCR ®), a provider of clinical research services focused on kidney research as well as a multitude of specialty therapeutic populations, ...
WALTHAM, Mass., December 04, 2025--(BUSINESS WIRE)--Wolters Kluwer Health today announced the launch of its new Advanced Compounding module for Simplifi 797, giving pharmacies a comprehensive solution ...
ROCKVILLE, Md., June 3, 2019 /PRNewswire/ -- USP released new and revised standards to help ensure the quality of compounded medicines. The updates pertain to the USP General Chapters on compounding ...
Purpose: The initial response of the pharmacy profession to United States Pharmacopeia (USP) chapter 797 and the current state of hospital pharmacy practice as it relates to implementing this chapter ...
On Nov. 1, the new U.S. Pharmacopoeia standards on sterile and nonsterile compounding will be implemented. Here’s what leaders need to know about USP 795 and USP 797: a. Nonpreserved aqueous dosage ...
Research supports the safety and efficacy of compounded lidocaine plus epinephrine for up to 24 hours at room temperature and ...
On June 15, 2012, the Office of Clinical Standards and Quality/Survey & Certification Group at CMS issued a memorandum regarding the CMS regulatory and policy requirements for repackaging single-dose ...
IV hydration clinics engage in sterile compounding activities (combining or mixing ingredients to create a custom drug/medicine for an individual patient), such as creating IV vitamin therapies, etc.
LINCOLN, Neb.--(BUSINESS WIRE)--Celerion, the premier provider of innovative early stage drug development solutions, announces the completion of a Clean Room and pharmacist certification to comply ...